Research summaries
The studies behind the answers
Each summary is the same shape: what they did, what they found, what it means for you. Plus a link to the original paper. No press-release exaggeration.
- Strong evidenceSleep, 2003 · 2003
Van Dongen et al — the cumulative cost of sleep restriction
- Lab study, 48 adults across four sleep schedules over 14 days.
- Six-hour nights for two weeks produced cognitive deficits matching 24-hour total deprivation.
- Subjective sleepiness plateaued after a few days — participants felt 'fine'.
- Performance kept degrading regardless. The dose was cumulative.
What it means — You cannot trust your own assessment of whether you're sleep-deprived. Track the input, not the feeling.
- Strong evidenceWhy We Sleep / Nature Communications · 2017
Walker — sleep deprivation and natural killer cell activity
- Healthy adults restricted to 4 hours of sleep for one night.
- Natural killer cell activity dropped by 70% the following day.
- Effect was dose-responsive — less sleep, more suppression.
- Recovery to baseline took multiple nights of full sleep.
What it means — The immune cost of short sleep is real and measurable, not abstract. One night moves the dial.
- Strong evidenceJAMA, 2009 · 2009
Morin et al — CBT-I vs medication for chronic insomnia
- Randomised trial comparing CBT-I and zolpidem in adults with chronic insomnia.
- Six weeks: both treatments roughly equivalent on sleep onset and total sleep time.
- 12 months: CBT-I gains held; pharmacological gains largely did not.
- Combined treatment outperformed either alone — but CBT-I alone outperformed medication alone long-term.
What it means — If you have chronic insomnia, CBT-I is the first-line treatment by every major guideline. The evidence is stronger than for any sleep drug.